UB Paderborn / Katalog / Suche / in CDI

Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors

Current medicinal chemistry, 2017-06, Vol.24 (19), p.2059

2017

Volltextzugriff (PDF)

Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line

International journal of molecular sciences, 2019-09, Vol.20 (19), p.4745

2019

Volltextzugriff (PDF)

Predictive Gene Signature for Pyrazolopyrimidine Derivative c‑Src Inhibitor 10a Sensitivity in Melanoma Cells

ACS medicinal chemistry letters, 2020-05, Vol.11 (5), p.928-932

2020

Volltextzugriff (PDF)

Optimization of Aminoimidazole Derivatives as Src Family Kinase Inhibitors

Molecules (Basel, Switzerland), 2018-09, Vol.23 (9), p.2369

2018

Volltextzugriff (PDF)

Probing the Binding Site of Abl Tyrosine Kinase Using in Situ Click Chemistry

ACS medicinal chemistry letters, 2013-02, Vol.4 (2), p.274-277

2013

Volltextzugriff (PDF)

Air and Bone Conduction Change After Stapedotomy and Partial Stapedectomy for Otosclerosis

Otolaryngology-head and neck surgery, 2005-07, Vol.133 (1), p.116-120

2005

Volltextzugriff (PDF)

Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment

Bioorganic & medicinal chemistry letters, 2018-11, Vol.28 (21), p.3454-3457

2018

Volltextzugriff (PDF)

Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma

European journal of medicinal chemistry, 2021-11, Vol.223, p.113653-113653, Article 113653

2021

Volltextzugriff (PDF)

Abstract 2201: Preclinical development of novel pyrazolo[3,4- d ]pyrimidines structure-based TKIs for the treatment of glioblastoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.2201-2201

2019

Volltextzugriff (PDF)

Prodrugs of Pyrazolo[3,4‑d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model

Journal of medicinal chemistry, 2017-07, Vol.60 (14), p.6305-6320

2017

Volltextzugriff (PDF)

High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 protein-protein interaction

Bioorganic & medicinal chemistry letters, 2014-01, Vol.24 (1), p.280-282

2014

Volltextzugriff (PDF)

Combining X‑ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4‑d]pyrimidines as Potent c‑Src Inhibitors Active in Vivo against Neuroblastoma

Journal of medicinal chemistry, 2015-01, Vol.58 (1), p.347-361

2015

Volltextzugriff (PDF)

Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: Preparation, characterization and cytotoxicity evaluation against neuroblastoma cell line

Bioorganic & medicinal chemistry letters, 2017-07, Vol.27 (14), p.3196-3200

2017

Volltextzugriff (PDF)

Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction

European journal of medicinal chemistry, 2018-09, Vol.157, p.743-758

2018

Volltextzugriff (PDF)

4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA–PB1 Protein–Protein Interaction: Structure–Activity Relationships Exploration with the Aid of Molecular Modeling

Journal of medicinal chemistry, 2016-03, Vol.59 (6), p.2688-2703

2016

Volltextzugriff (PDF)

Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma

European journal of medicinal chemistry, 2017-02, Vol.127, p.369-378

2017

Volltextzugriff (PDF)

Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines

European journal of medicinal chemistry, 2019-11, Vol.181, p.111545-111545, Article 111545

2019

Volltextzugriff (PDF)

Insight into the Allosteric Inhibition of Abl Kinase

Journal of chemical information and modeling, 2014-05, Vol.54 (5), p.1325-1338

2014

Volltextzugriff (PDF)

Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors

Expert opinion on therapeutic patents, 2017-12, Vol.27 (12), p.1305-1318

2017

Volltextzugriff (PDF)

Design, Synthesis, and Biological Evaluation of Pyrazolo[3,4‑d]pyrimidines Active in Vivo on the Bcr-Abl T315I Mutant

Journal of medicinal chemistry, 2013-07, Vol.56 (13), p.5382-5394

2013

Volltextzugriff (PDF)

Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors

ChemMedChem, 2015-12, Vol.10 (12), p.2027-2041

2015

Volltextzugriff (PDF)

Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors

Journal of medicinal chemistry, 2015-06, Vol.58 (11), p.4590-4609

2015

Volltextzugriff (PDF)

The Fight against the Influenza A Virus H1N1: Synthesis, Molecular Modeling, and Biological Evaluation of Benzofurazan Derivatives as Viral RNA Polymerase Inhibitors

ChemMedChem, 2014-01, Vol.9 (1), p.129-150

2014

Volltextzugriff (PDF)

One-pot synthesis of spiro(indoline-3,4′-pyrazolo[3,4-b]pyridine)-5′-carbonitriles as p53-MDM2 interaction inhibitors

Future medicinal chemistry, 2018-12, Vol.10 (24), p.2771-2789

2018

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Pyrrolo[2,3-d]Pyrimidines as Kinase Inhibitors

Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line

Predictive Gene Signature for Pyrazolopyrimidine Derivative c‑Src Inhibitor 10a Sensitivity in Melanoma Cells

Optimization of Aminoimidazole Derivatives as Src Family Kinase Inhibitors

A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4- d ]Pyrimidine Dual Src/P-Glycoprotein Inhibitor

Probing the Binding Site of Abl Tyrosine Kinase Using in Situ Click Chemistry

Air and Bone Conduction Change After Stapedotomy and Partial Stapedectomy for Otosclerosis

Efficient optimization of pyrazolo[3,4-d]pyrimidines derivatives as c-Src kinase inhibitors in neuroblastoma treatment

Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma

Abstract 2201: Preclinical development of novel pyrazolo[3,4- d ]pyrimidines structure-based TKIs for the treatment of glioblastoma

Prodrugs of Pyrazolo[3,4‑d]pyrimidines: From Library Synthesis to Evaluation as Potential Anticancer Agents in an Orthotopic Glioblastoma Model

High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 protein-protein interaction

Combining X‑ray Crystallography and Molecular Modeling toward the Optimization of Pyrazolo[3,4‑d]pyrimidines as Potent c‑Src Inhibitors Active in Vivo against Neuroblastoma

Pyrazolo[3,4-d]pyrimidines-loaded human serum albumin (HSA) nanoparticles: Preparation, characterization and cytotoxicity evaluation against neuroblastoma cell line

Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction

4,6-Diphenylpyridines as Promising Novel Anti-Influenza Agents Targeting the PA–PB1 Protein–Protein Interaction: Structure–Activity Relationships Exploration with the Aid of Molecular Modeling

Identification of new pyrrolo[2,3-d]pyrimidines as Src tyrosine kinase inhibitors in vitro active against Glioblastoma

Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell lines

Insight into the Allosteric Inhibition of Abl Kinase

Pyrrolo[2,3-d]pyrimidines active as Btk inhibitors

Design, Synthesis, and Biological Evaluation of Pyrazolo[3,4‑d]pyrimidines Active in Vivo on the Bcr-Abl T315I Mutant

Identification of Aminoimidazole and Aminothiazole Derivatives as Src Family Kinase Inhibitors

Studies on the ATP Binding Site of Fyn Kinase for the Identification of New Inhibitors and Their Evaluation as Potential Agents against Tauopathies and Tumors

The Fight against the Influenza A Virus H1N1: Synthesis, Molecular Modeling, and Biological Evaluation of Benzofurazan Derivatives as Viral RNA Polymerase Inhibitors

One-pot synthesis of spiro(indoline-3,4′-pyrazolo[3,4-b]pyridine)-5′-carbonitriles as p53-MDM2 interaction inhibitors

Suchergebnisse filtern